Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety and Efficacy of WC3011 in Vulvovaginal Atrophy
NCT01455597Phase 3Completed
- Sponsor
- Warner Chilcott
- Start
- Oct 2011
- Primary completion
- Dec 2012
- Countries
- 1
01
Overview
A Phase 3 trial of estradiol topical in Vulvovaginal atrophy (VVA), sponsored by Warner Chilcott. Started Oct 2011; status: completed.
02
Drugs
estradiol topical
03
Conditions
Vulvovaginal atrophy (VVA)
Beyond the preview
Go deeper on NCT01455597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01455597.